These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 24852140)
21. The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development. van der Geize R; Grommen AW; Hessels GI; Jacobs AA; Dijkhuizen L PLoS Pathog; 2011 Aug; 7(8):e1002181. PubMed ID: 21901092 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia. Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456 [TBL] [Abstract][Full Text] [Related]
23. Virulence-associated protein-specific serum immunoglobulin G-isotype expression in young foals protected against Rhodococcus equi pneumonia by oral immunization with virulent R. equi. Hooper-McGrevy KE; Wilkie BN; Prescott JF Vaccine; 2005 Dec; 23(50):5760-7. PubMed ID: 16112256 [TBL] [Abstract][Full Text] [Related]
24. Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response. Lohmann KL; Lopez AM; Manning ST; Marques FJ; Brownlie R; Allen AL; Sangster AE; Mutwiri G; Gerdts V; Potter A; Townsend HG Can J Vet Res; 2013 Jul; 77(3):161-9. PubMed ID: 24101791 [TBL] [Abstract][Full Text] [Related]
25. Characterization of the role of the pathogenicity island and vapG in the virulence of the intracellular actinomycete pathogen Rhodococcus equi. Coulson GB; Agarwal S; Hondalus MK Infect Immun; 2010 Aug; 78(8):3323-34. PubMed ID: 20439471 [TBL] [Abstract][Full Text] [Related]
26. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses. Prescott JF; Fernandez AS; Nicholson VM; Patterson MC; Yager JA; Viel L; Perkins G Equine Vet J; 1996 Sep; 28(5):344-9. PubMed ID: 8894530 [TBL] [Abstract][Full Text] [Related]
27. Identification of a VapA virulence factor functional homolog in Rhodococcus equi isolates housing the pVAPB plasmid. Willingham-Lane JM; Coulson GB; Hondalus MK PLoS One; 2018; 13(10):e0204475. PubMed ID: 30286098 [TBL] [Abstract][Full Text] [Related]
28. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses. Hines MT; Paasch KM; Alperin DC; Palmer GH; Westhoff NC; Hines SA Vet Immunol Immunopathol; 2001 May; 79(1-2):101-14. PubMed ID: 11356253 [TBL] [Abstract][Full Text] [Related]
29. Analyses of lipid rafts, Toll-like receptors 2 and 4, and cytokines in foals vaccinated with Virulence Associated Protein A/CpG oligonucleotide vaccine against Rhodococcus equi. Kaur N; Townsend H; Lohmann K; Marques F; Singh B Vet Immunol Immunopathol; 2013 Dec; 156(3-4):182-9. PubMed ID: 24422228 [TBL] [Abstract][Full Text] [Related]
30. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Jacks S; Giguère S; Prescott JF Clin Vaccine Immunol; 2007 Apr; 14(4):369-74. PubMed ID: 17301216 [TBL] [Abstract][Full Text] [Related]
31. Virulent and avirulent Rhodococcus equi infection in T-cell deficient athymic nude mice: pathologic, bacteriologic and immunologic responses. Madarame H; Takai S; Matsumoto C; Minamiyama K; Sasaki Y; Tsubaki S; Hasegawa Y; Nakane A FEMS Immunol Med Microbiol; 1997 Apr; 17(4):251-62. PubMed ID: 9143883 [TBL] [Abstract][Full Text] [Related]
32. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103+. Pei Y; Nicholson V; Woods K; Prescott JF Vet Microbiol; 2007 Nov; 125(1-2):100-10. PubMed ID: 17560744 [TBL] [Abstract][Full Text] [Related]
33. Vaccination of mice with salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection. Oliveira AF; Ruas LP; Cardoso SA; Soares SG; Roque-Barreira MC PLoS One; 2010 Jan; 5(1):e8644. PubMed ID: 20072623 [TBL] [Abstract][Full Text] [Related]
34. B-Cell epitope mapping of the VapA protein of Rhodococcus equi: implications for early detection of R. equi disease in foals. Vanniasinkam T; Barton MD; Heuzenroeder MW J Clin Microbiol; 2001 Apr; 39(4):1633-7. PubMed ID: 11283104 [TBL] [Abstract][Full Text] [Related]
35. Live virulent Rhodococcus equi, rather than killed or avirulent, elicits protective immunity to R. equi infection in mice. Takai S; Kobayashi C; Murakami K; Sasaki Y; Tsubaki S FEMS Immunol Med Microbiol; 1999 May; 24(1):1-9. PubMed ID: 10340706 [TBL] [Abstract][Full Text] [Related]
36. Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia. Sanz MG; Oliveira AF; Loynachan A; Page A; Svansson V; Giguère S; Horohov DW Equine Vet J; 2016 Jan; 48(1):103-8. PubMed ID: 25257622 [TBL] [Abstract][Full Text] [Related]
37. The effect of experimental infection with Rhodococcus equi on immunodeficient mice. Yager JA; Prescott CA; Kramar DP; Hannah H; Balson GA; Croy BA Vet Microbiol; 1991 Aug; 28(4):363-76. PubMed ID: 1949550 [TBL] [Abstract][Full Text] [Related]
38. Disseminated Rhodococcus equi infection in dromedary camels (Camelus dromedarius). Kinne J; Madarame H; Takai S; Jose S; Wernery U Vet Microbiol; 2011 Apr; 149(1-2):269-72. PubMed ID: 21035967 [TBL] [Abstract][Full Text] [Related]